{"listing":{"listing_type":"company","name":"Oyster Therapeutics","slug":"oyster-therapeutics","tagline":"Brain-penetrant targeted protein degraders","description":"London biotech, formerly Kesmalea Therapeutics, developing small oral targeted protein degraders via its SELFTAC platform, led by a tau degrader for Alzheimer's.","url":"https://www.oyster-tx.com/","is_stealth":false,"normalized_domain":"oyster-tx.com","normalized_url_key":"oyster-tx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cdn.prod.website-files.com/6aeb4e155d500a0307ff75e5/6aeb6a8fe0b5e59ff69c9008_oyster-tx-webclip.png","links":[],"entry_points":[{"kind":"homepage","url":"https://www.oyster-tx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.oyster-tx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"99b06367-b402-4170-b27c-3838f6335bf7"},"categories":["Biotech","Drug Discovery","Neuroscience"],"stage":null,"founded_year":null,"location":"London, UK","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-11-11T04:19:31.705Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-11-11T04:19:36.904Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"neuroscience","name":"Neuroscience","note":null,"profile_url":"/industries/neuroscience"}]}}